symtuza: Clinical Trials

2 trials of symtuza, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow symtuza: new trials by email Literature Review of symtuza trials Research Report on symtuza

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'
Biktarvy, Symtuza - Human Immunodeficiency Virus
Phase 3CompletedChelsea and Westminster NHS Foundation Trust362020-09-302024-02-08
The Late Presenter Treatment Optimisation Study
Biktarvy, Symtuza - HIV/AIDS
Phase 3CompletedNEAT ID Foundation4472019-03-052025-12-17

Conditions studied

Acquired Immunodeficiency Syndrome (2)

Sponsors

Chelsea and Westminster NHS Foundation Trust (1)  ·  NEAT ID Foundation (1)

Countries

United Kingdom (2)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Georg Behrens (1)  ·  Marta Boffito, MD PhD FRCP (1)

Results publications

PMID 39763430, PMID 41344354

NIH funding

2019 (1)